148 related articles for article (PubMed ID: 34757229)
21. hTERT-molecular targeted therapy of ovarian cancer cells via folate-functionalized PLGA nanoparticles co-loaded with MNPs/siRNA/wortmannin.
Ghareghomi S; Ahmadian S; Zarghami N; Hemmati S
Life Sci; 2021 Jul; 277():119621. PubMed ID: 34004255
[TBL] [Abstract][Full Text] [Related]
22. Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid
Li W; Yan R; Liu Y; He C; Zhang X; Lu Y; Khan MW; Xu C; Yang T; Xiang G
Drug Deliv; 2019 Dec; 26(1):794-802. PubMed ID: 31366257
[TBL] [Abstract][Full Text] [Related]
23. Co-delivery of doxorubicin and Bmi1 siRNA by folate receptor targeted liposomes exhibits enhanced anti-tumor effects in vitro and in vivo.
Yang T; Li B; Qi S; Liu Y; Gai Y; Ye P; Yang G; Zhang W; Zhang P; He X; Li W; Zhang Z; Xiang G; Xu C
Theranostics; 2014; 4(11):1096-111. PubMed ID: 25285163
[TBL] [Abstract][Full Text] [Related]
24. Development of hyaluronic acid-anchored polycaprolactone nanoparticles for efficient delivery of PLK1 siRNA to breast cancer.
Jain D; Yadav AK
Drug Deliv Transl Res; 2023 Jun; 13(6):1730-1744. PubMed ID: 36641487
[TBL] [Abstract][Full Text] [Related]
25. Targeted nanodelivery of siRNA against KRAS G12D inhibits pancreatic cancer.
Huang R; Du H; Cheng L; Zhang P; Meng F; Zhong Z
Acta Biomater; 2023 Sep; 168():529-539. PubMed ID: 37451658
[TBL] [Abstract][Full Text] [Related]
26. Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery.
Xu L; Yeudall WA; Yang H
Acta Biomater; 2017 Jul; 57():251-261. PubMed ID: 28438704
[TBL] [Abstract][Full Text] [Related]
27. Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo.
Wei Y; Sun Y; Wei J; Qiu X; Meng F; Storm G; Zhong Z
J Control Release; 2021 Sep; 337():521-529. PubMed ID: 34352315
[TBL] [Abstract][Full Text] [Related]
28. Antiviral activity of PLK1-targeting siRNA delivered by lipid nanoparticles in HBV-infected hepatocytes.
Foca A; Dhillon A; Lahlali T; Lucifora J; Salvetti A; Rivoire M; Lee A; Durantel D
Antivir Ther; 2020; 25(3):151-162. PubMed ID: 32496211
[TBL] [Abstract][Full Text] [Related]
29. A hierarchical assembly strategy to engineer dextran-enveloped polyurethane nanopolyplexes for robust ovarian cancer gene therapy.
Lou B; Jin R; Cheng J; Wen X; Zhao P; Lin C
Acta Biomater; 2018 Sep; 78():260-273. PubMed ID: 30071349
[TBL] [Abstract][Full Text] [Related]
30. GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment.
Zou Y; Xia Y; Meng F; Zhang J; Zhong Z
Mol Pharm; 2018 Sep; 15(9):3664-3671. PubMed ID: 29570299
[TBL] [Abstract][Full Text] [Related]
31. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
[TBL] [Abstract][Full Text] [Related]
32. In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas.
Amjad MW; Amin MC; Katas H; Butt AM; Kesharwani P; Iyer AK
Mol Pharm; 2015 Dec; 12(12):4247-58. PubMed ID: 26567518
[TBL] [Abstract][Full Text] [Related]
33. Boosting RNAi therapy for orthotopic glioblastoma with nontoxic brain-targeting chimaeric polymersomes.
Shi Y; Jiang Y; Cao J; Yang W; Zhang J; Meng F; Zhong Z
J Control Release; 2018 Dec; 292():163-171. PubMed ID: 30408555
[TBL] [Abstract][Full Text] [Related]
34. Virus-Mimicking Chimaeric Polymersomes Boost Targeted Cancer siRNA Therapy In Vivo.
Zou Y; Zheng M; Yang W; Meng F; Miyata K; Kim HJ; Kataoka K; Zhong Z
Adv Mater; 2017 Nov; 29(42):. PubMed ID: 28961339
[TBL] [Abstract][Full Text] [Related]
35. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.
Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z
Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765
[TBL] [Abstract][Full Text] [Related]
36. Folate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance.
Jones SK; Lizzio V; Merkel OM
Biomacromolecules; 2016 Jan; 17(1):76-87. PubMed ID: 26636884
[TBL] [Abstract][Full Text] [Related]
37. Targeting polo-like kinase 1 enhances radiation efficacy for head-and-neck squamous cell carcinoma.
Gerster K; Shi W; Ng B; Yue S; Ito E; Waldron J; Gilbert R; Liu FF
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):253-60. PubMed ID: 20394857
[TBL] [Abstract][Full Text] [Related]
38. Selective Cell Penetrating Peptide-Functionalized Envelope-Type Chimeric Lipopepsomes Boost Systemic RNAi Therapy for Lung Tumors.
Qiu M; Ouyang J; Wei Y; Zhang J; Lan Q; Deng C; Zhong Z
Adv Healthc Mater; 2019 Aug; 8(16):e1900500. PubMed ID: 31231966
[TBL] [Abstract][Full Text] [Related]
39. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
[TBL] [Abstract][Full Text] [Related]
40. Revisiting the value of competition assays in folate receptor-mediated drug delivery.
Jones SK; Sarkar A; Feldmann DP; Hoffmann P; Merkel OM
Biomaterials; 2017 Sep; 138():35-45. PubMed ID: 28551461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
